Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT00724451
Eligibility Criteria:
Inclusion Criteria:
* Willingness to sign an Informed Consent
* Male and female patients \>=18 years of age with Chronic Hepatitis C
* Not previously treated with Peg-Interferons
* Positive for serum hepatitis C virus (HCV)-ribonucleic acid (RNA)
Exclusion Criteria:
* Previous treatment with peginterferon
* Participation in a therapeutic Good Clinical Practice (GCP) clinical study within 30 days prior to study start
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00724451
Study Brief:
Protocol Section:
NCT00724451